Clinical Trials Directory

Trials / Completed

CompletedNCT02772133

Circulating PRCP in STEMI Patients Undergoing Primary PCI

Status
Completed
Phase
Study type
Observational
Enrollment
275 (actual)
Sponsor
Qilu Hospital of Shandong University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Purpose: The purpose of this study is to evaluate the impact of acute ST-segment elevation myocardial infarction (STEMI) and primary percutaneous coronary intervention (PCI) on circulating prolylcarboxypeptidase (PRCP) level and activity.

Conditions

Interventions

TypeNameDescription
PROCEDUREPrimary PCI

Timeline

Start date
2016-05-01
Primary completion
2016-07-01
Completion
2016-07-01
First posted
2016-05-13
Last updated
2020-01-03

Locations

4 sites across 1 country: China

Source: ClinicalTrials.gov record NCT02772133. Inclusion in this directory is not an endorsement.

Circulating PRCP in STEMI Patients Undergoing Primary PCI (NCT02772133) · Clinical Trials Directory